TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Bright Minds Biosciences Inc (DRUG)

Healthcare Biotechnology
73.80 $
+0.7% vs. previous close
Closing price · As of: 3. Aug 2026

Bright Minds Biosciences Inc (DRUG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 312 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Balance Sheet DRUG
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
8.5 6.9 6.9 6.5 6.3 6.1 58 56 52 84 91 312
8.4 6.8 6.8 6.5 6.3 6.0 58 56 52 84 91 312
8.1 6.7 6.8 5.9 6.2 5.7 58 56 51 83 89 309
8.1 6.7 6.8 5.9 6.2 5.7 58 56 51 83 89 309
0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.3 0.4 0.5 1.1
0.0
0.7 0.3 0.9 0.8 0.2 0.6 0.6 0.7 0.7 2.4 1.6 3.8
0.7 0.3 0.9 0.8 0.2 0.5 0.5 0.6 0.6 2.3 1.6 3.8
0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1
0.6 0.2 0.8 0.8 0.1 0.4 0.4 0.6 0.5 1.7 1.4 3.6
7.7 6.6 6.0 5.7 6.1 5.5 58 56 52 82 89 308
-30 -32 -33 -34 -34 -34 -34 -37 -42 -47 -54 -65
3.8 3.8 3.8 4.5 4.6 4.6 4.6 4.6 7.1 7.2 7.8 9.6

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?